B. Riley analyst Nick Giles raised the firm's price target on United States Antimony to $13 from $11 and keeps a Buy rating on the shares. While the delay of the Thompson Falls expansion is a near-term "blemish," the price target is being raised due to the increased scope of feedstock procurement and the continued prioritization of domestic antimony supply, the analyst tells investors in a research note.
